Health insurance stocks drop on new ‘Medicare for All’ bill, drug hearings

Healthcare stock declines are being led by losses in the health insurance sector after Democrats introduced a new “Medicare for All” bill that would replace private health plans with a government option, according to Bloomberg.

Advertisement

The S&P 500 Managed Health Care Index fell as much as 4.9 percent, the index’s biggest percent decrease since Dec. 6. In addition to Medicare for All efforts, Bloomberg said some of the declines could be linked to the Senate’s drug price hearing Feb. 26, during which pharmaceutical companies pushed some of the blame for drug pricing issues on drug-plan middlemen.

UnitedHealth Group and Cigna were down about 4 percent. CVS Health, which owns Aetna, fell 2 percent. Humana and WellCare Health Plans also dipped.

More articles on payers:
BCBS of Michigan accused of charging hidden fees
UnityPoint back in network with Humana, Molina
Anthem study: Employers are increasingly bundling health benefits

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Capital

Advertisement

Comments are closed.